Merck & Company (DE:6MK)
XETRA:6MK
Holding DE:6MK?
Track your performance easily

Merck & Company (6MK) Income Statement

61 Followers

Merck & Company Income Statement

Last quarter (Q3 2024), Merck & Company's total revenue was $16.66B, an increase of 4.35% from the same quarter last year. In Q3, Merck & Company's net income was $3.16B. See Merck & Company’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 63.17B$ 60.12B$ 59.28B$ 48.70B$ 41.52B$ 46.84B
Cost of Revenue
$ 15.28B$ 16.13B$ 17.41B$ 13.63B$ 13.62B$ 14.11B
Gross Profit
$ 47.90B$ 43.99B$ 41.87B$ 35.08B$ 27.90B$ 32.73B
Operating Expense
$ 39.56B$ 41.03B$ 23.59B$ 21.88B$ 22.35B$ 20.49B
Operating Income
$ 8.33B$ 2.95B$ 18.28B$ 13.20B$ 5.55B$ 12.24B
Net Non Operating Interest Income Expense
$ -273.00M$ -781.00M$ -805.00M$ -770.00M$ -772.00M$ -619.00M
Other Income Expense
$ -532.00M$ -284.00M$ -1.03B$ -1.34B$ -890.00M$ 139.00M
Pretax Income
$ 8.00B$ 1.89B$ 16.44B$ 13.88B$ 5.86B$ 11.46B
Tax Provision
$ 1.56B$ 1.51B$ 1.92B$ 1.52B$ 1.34B$ 1.69B
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ 12.15B$ 365.00M$ 14.52B$ 13.05B$ 4.52B$ 9.84B
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 54.84B$ 57.16B$ 41.00B$ 35.51B$ 35.97B$ 34.60B
Net Income From Continuing And Discontinued Operation
$ 12.15B$ 365.00M$ 14.52B$ 13.05B$ 7.07B$ 9.84B
Normalized Income
$ 10.71B$ 2.90B--$ 5.29B$ 10.64B
Interest Expense
------
EBIT
$ 14.64B$ 3.04B$ 17.41B$ 14.69B$ 6.69B$ 12.36B
EBITDA
$ 18.91B$ 6.91B$ 21.32B$ 17.90B$ 10.18B$ 16.03B
Currency in USD

Merck & Company Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis